Operational Framework: Management of Common Cancers

Objectives

Establish an integrated, population-based framework for prevention, screening, early detection, diagnosis, treatment, follow-up, rehabilitation and palliative care for common cancers, embedded within the wider non-communicable disease strategy and regular public health system.[1][2][3]The framework prioritises oral, cervical and breast cancers because they are common, suitable for early detection and have substantial potential for cure.[2][4]

• Improve early detection, timely treatment and long-term follow-up to reduce premature mortality, improve survival and enhance quality of life.[1][5]
• Prioritise prevention, risk-factor screening and health promotion, recognising shared risk factors across cancer, diabetes and cardiovascular disease.[1]
• Ensure equitable, affordable and universal access to prevention, screening and treatment, particularly for poor, vulnerable, marginalised and underserved populations.[2][4][6]
• Screen adults aged over 30 years for oral cancer and women aged over 30 years for cervical and breast cancers, with particular priority for people who use tobacco in oral-cancer screening.[7][8]
• Deliver routine screening every five years using oral visual examination, visual inspection with acetic acid and clinical breast examination, while allowing symptomatic people to access screening irrespective of age.[8][9]
• Expand planned population coverage in phases from 50% in the first year to 65% in the second and 80% in the third year for adults aged 30 to 65 years in target populations.[10]
• Link screening with confirmatory diagnosis, management of precancerous disease, cancer treatment, risk reduction, follow-up and community support so that screening contributes to reduced morbidity and mortality.[6][3]
• Provide a broader blueprint for other cancers while adapting implementation to state and local needs without compromising core principles or clinical standards.[2][4]

Implementation

Implement cancer control through the National Health Mission and the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke, rather than as a separate vertical programme.[2][4]States are expected to adapt the framework, use and supplement existing resources, establish referral networks and lead delivery through the public health system.[4][11]

• Phase implementation by beginning in selected, well-performing districts, using the initial six months for planning, recruitment where needed, communication, capacity-building and state-specific rollout arrangements.[3]
• Use sub-centres, health and wellness centres and primary health centres as first-level screening sites, with auxiliary nurse midwives, mid-level providers and staff nurses delivering screening in private settings with suitable equipment and training.[8]
• Organise primary health centres as screening and population-record hubs, community health centres for assessment and selected diagnostic procedures, and district hospitals for confirmation, training and onward referral.[12]
• Strengthen district hospitals as first referral points, including capacity for breast ultrasound, colposcopy, cryotherapy, loop electrosurgical excision procedure and biopsy; enable suitably equipped community health centres to provide comparable services where feasible.[3][10]
• Develop district-level histopathology capacity through local or clustered services, designated Free Diagnostics Services facilities or credible partnerships, reducing travel requirements and loss to follow-up.[11][9]
• Refer screen-positive people promptly for examination, confirmation, further investigation and management, and ensure forward and backward referrals between screening sites, diagnostic facilities, district hospitals and tertiary cancer centres.[7][3][10]
• Provide confirmed cancer treatment at tertiary centres, regional cancer care centres or medical colleges, with follow-up through district hospitals and community health centres.[13][9]
• Strengthen workforce capacity through staff review, redeployment and cascade training led by national, state and district trainer cadres.[12][14]
• Train providers in screening, confirmatory procedures, counselling, communication of positive results, patient reassurance, referral follow-up, recording, reporting and programme operations.[12][14]
• Use district hospitals as training hubs, medical colleges for specialist and advanced-care training, and tertiary centres for training medical officers in cryotherapy.[10][9]
• Update and disseminate standard treatment guidelines, and provide communication on treatment options, care levels, financial support, support networks, tobacco and alcohol reduction and possible complications.[14]
• Engage government, communities, Panchayati Raj Institutions, frontline workers, non-governmental organisations, private-sector partners, cancer-care institutions and community-based organisations in treatment support, rehabilitation and palliative care.[1][11][9]
• Assign district non-communicable disease cells responsibility for planning, monitoring and reporting, and adapt the existing programme monitoring framework to include cancer-screening indicators.[3][14]
• Use cancer registries, accessible clinical documentation, clinical handover, periodic population surveys and screening follow-up to strengthen information on cancer burden, service access, incidence, mortality and risk factors.[1][6][14]

The available text does not specify a detailed national governance structure, implementation timetable beyond phased rollout, indicator targets, reporting formats, formal accountability arrangements or quantified programme budget.[15][7][14][16]

Monitoring & Evaluation

Monitoring is intended to be integrated into the cancer-screening framework through strengthened registries, routine programme monitoring, referral tracking, accessible clinical documentation and use of existing non-communicable disease monitoring systems.[1][15][7][3]

• Strengthen cancer registries and research on cancer burden, patterns, impacts on poorer populations and locally appropriate risk-factor strategies.[1]
• Use National Cancer Registry Programme estimates and International Agency for Research on Cancer projections to characterise the national cancer burden.[13]
• Adapt the monitoring framework for the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke to incorporate indicators for the proposed cancer-screening framework.[14]
• Use the National Non-Communicable Diseases Monitoring Framework and the framework implementation monitoring plan to support oversight.[7]
• Assign District Non-Communicable Disease cells responsibility for programme planning, monitoring and reporting.[3]
• Track annual population coverage during the three-year rollout, which is planned to rise from 50% in year one to 65% in year two and 80% in year three.[10]
• Screen eligible populations every five years and ensure that people with positive or abnormal results are followed up until they access required diagnostic and treatment services.[8][9]
• Maintain accessible documentation across levels of care, establish clinical handovers, and link screening programmes with cancer registries to improve information on incidence, prevalence and morbidity.[6]
• Use periodic surveys, including the National Family Health Survey, National Sample Survey Organisation and District Level Household Surveys, to assess cancer incidence and mortality, screening access, tobacco and alcohol use, and obesity.[14]
• Monitor referral pathways by linking each screening site to diagnosis and treatment facilities and referring screen-positive individuals for confirmation, investigation and management.[10]
• Recognise that higher false-positive rates may occur during the first two years of implementation as peripheral providers gain confidence, and use follow-up arrangements to address these early challenges.[3]

The supplied text does not provide a complete indicator set, indicator definitions or targets beyond coverage, a reporting timetable or format, formal evaluation methods, surveillance procedures, or named accountability bodies.[4][11][6][7][14]

Costing & Financing

Financing relies principally on National Health Mission support, existing public-health programme structures, state budgets and social protection schemes, while seeking to reduce the substantial financial hardship associated with cancer care.[4][13][5][16]

• Fund the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke through the National Health Mission.[13]
• Leverage National Health Mission support, state budgets and existing resources, with states expected to supplement available resources for local implementation.[4][11]
• Link cancer treatment to central and state social protection schemes, free medicines and diagnostics initiatives, and health-protection arrangements to mitigate treatment costs.[1][16]
• Protect patients from financial hardship, recognising the economic effects of premature death, lost productivity, illness and treatment on individuals, households and society.[1][16]
• Use existing human resources and programme structures where possible, while considering additional staff where workload pressures are high.[7]
• Resource implementation requirements including personnel, training, equipment, consumables, infrastructure, histopathology, referral capacity and partnerships, although no monetary values are provided.[3][9]
• Provide states with additional costing details separately and encourage use of National Health Mission and state-level health-protection schemes.[16]
• Recognise that cancer treatment costs are high and that almost three quarters of cancer expenditure in India is paid out of pocket despite government welfare schemes.[13]
• Recognise that the odds of catastrophic hospitalisation expenditure for cancer are about 160% higher than for communicable disease, and that catastrophic cancer spending is nearly double that associated with accidents and cardiovascular disease.[13]
• Frame clinical breast examination and visual inspection with acetic acid as cost-effective approaches, and cervical screening linked to treatment as life-saving and cost-saving.[5]

The supplied text does not specify a quantified programme budget, allocations, unit costs, funding gap, resource-mobilisation target, currency-denominated commitment or economic assumptions.[1][4][5][3][16]